DUBLIN--(BUSINESS WIRE)--Sep 11, 2018--The "Cutaneous T-Cell Lymphoma(CTCL) - Epidemiology Insights to 2025" report has been added to ResearchAndMarkets.com's offering.

Cutaneous T Cell Lymphoma( CTCL) - Epidemiology Forecast, 2025 provides an overview of the epidemiology trends of Cutaneous T Cell Lymphoma (CTCL) in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data..

The report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical needs associated with the Insulin Resistance. The report contains the targeted patient populations and the forecast methodology.

Key Coverage and Benefits:

The report includes the prevalent population and how will it change over the next eight years. Coverage of key Cutaneous T Cell Lymphoma (CTCL) sub-populations and its prevalent or incident cases Prevalent or incident cases segmented by age and sex. The key differences in epidemiology patterns across the seven market segments.

Key Topics Covered:

1. Report Introduction

2. Snapshot of Total Prevalent or Incident cases by 7 MM

3. Executive Summary

4. Cutaneous T Cell Lymphoma (CTCL) Overview

5. Risk Factors Associated with Cutaneous T Cell Lymphoma (CTCL)

6. Disease Burden & Unmet Need in the Market

7. Epidemiology and Patient Populations

8. Prevalent & Incident Cases by 7 MM-2015-2025

9. Key Takeaways

10. Appendix

For more information about this report visit https://www.researchandmarkets.com/research/sj3kzr/global_cutaneous?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180911005393/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Hematology



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/11/2018 07:05 AM/DISC: 09/11/2018 07:05 AM